Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pitthaporn Chotikanokrat"'
Autor:
Unchalee Permsuwan, Chaicharn Deerochanawong, Pitthaporn Chotikanokrat, Arvind Vilas Gadekar, Natapong Kosachunhanun
Publikováno v:
ClinicoEconomics and Outcomes Research. 11:423-430
Aim Liraglutide, a once-daily subcutaneous glucagon-like peptide-1 (GLP-1) agonist, is approved for treatment of hyperglycemia in patients with type 2 diabetes mellitus (T2DM). For patients with established cardiovascular diseases, liraglutide has al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1040f775ff7597dfa161cf0a7c0e7ecf
https://doi.org/10.2147/ceor.s201951
https://doi.org/10.2147/ceor.s201951
Autor:
Natapong Kosachunhanun, Pitthaporn Chotikanokrat, Chaicharn Deerochanawong, Unchalee Permsuwan
Objective: To assess the financial consequences of different adoption rate of Biphasic Insulin Aspart (BIAsp) 30 instead of Biphasic Human Insulin (BHI) 30 for people with type 2 diabetes (T2DM) in Thailand from the payer’s perspective. Methods: Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c127b07df9da62ff0df0b35210ace1
Autor:
Chaicharn Deerochanawong, Natapong Kosachunhanun, Pitthaporn Chotikanokrat, Unchalee Permsuwan, Deerochanawong, Chaicharn, Kosachunhanun, Natapong, Chotikanokrat, Pitthaporn, Permsuwan, Unchalee
Publikováno v:
Current Medical Research & Opinion; Feb2018, Vol. 34 Issue 2, p369-375, 7p